U.S. Electric Utilities Stock News

In early June 2026, Eli Lilly reported Phase 3 data showing its oral GLP-1 Foundayo delivered significant weight loss across menopausal stages, while its investigational triple-agonist retatrutide produced substantial weight loss and improvements in obesity-related conditions such as knee osteoarthritis pain, obstructive sleep apnea, and type 2 diabetes. Together with broadened insurance coverage for Zepbound and Foundayo and new LillyDirect partnerships, these results point to Eli Lilly...

In late May 2026, Appian participated in TD Cowen's 54th Annual Technology, Media & Telecom Conference in New York and William Blair's 46th Annual Growth Stock Conference in Chicago, with Chief Financial Officer Srdjan Tanjga presenting the company's latest performance and outlook. These appearances followed a strong first quarter where Appian exceeded revenue expectations yet paired the beat with comparatively cautious full-year guidance, highlighting the tension between current execution...

The Morning Bull - US Market Morning Update Monday, Jun, 8 2026 US stock futures are pointing sharply lower this morning, with E mini S&P 500 contracts down about 2.6% and Nasdaq 100 futures off nearly 4.8%, as investors react to stronger than expected US jobs data and a jump in market volatility. Nonfarm payrolls rose by 172,000 in May and unemployment held at 4.3%, while wages grew 0.3% month over month, signaling a job market that is still firm and keeping alive the prospect of another...

Goodyear Tire & Rubber (GT) has moved back into the spotlight after revealing it will supply specialized lunar tires for Lunar Outpost’s Pegasus Lunar Terrain Vehicle, which is part of NASA’s Artemis missions that are planned to begin supporting astronauts in 2028. See our latest analysis for Goodyear Tire & Rubber. Despite the Artemis contract drawing fresh attention, Goodyear’s recent trading tells a different story. The stock’s 30-day share price return is down 12.22% and its 1-year total...

Spire (SR) is back in focus after its latest second quarter update, where adjusted earnings came in slightly below estimates, revenue declined year over year, and management reset 2026 guidance alongside a new long term capital plan. See our latest analysis for Spire. Following the earnings reset and long term capital plan, Spire’s recent share price has been choppy, with the stock down over the past quarter but supported by a 1 year total shareholder return of 16.13% and a 5 year total...

Community Trust Bancorp recently highlighted its status as a higher-yield payer, with a 3.15% dividend and a record of increasing payouts five times over the past five years. Analysts now expect nearly 12% earnings growth for fiscal 2026, reinforcing the bank’s appeal to income-focused investors who prioritize consistent dividends. With this backdrop of rising dividends, we’ll examine how the earnings growth outlook shapes Community Trust Bancorp’s broader investment narrative. The latest...

Bentley Systems (BSY) drew fresh investor attention after reporting Q1 2026 results that included 14.5% year-over-year revenue growth, higher subscription and ARR figures, and a new US$550 million term loan alongside repayment of convertible notes. See our latest analysis for Bentley Systems. Despite the solid Q1 update and focus on AI driven workflows, the share price at US$32.93 reflects pressure, with the 90 day share price return down 15.5% and the 1 year total shareholder return down...

If you are wondering whether CoStar Group at around US$33.89 is starting to look like value or still overpriced, the key is to understand what the current share price actually reflects. The stock is roughly flat over the last 7 days at up 0.1% and up 3.4% over the last 30 days, but the longer term picture is much weaker with the share price down 48.4% year to date and down 57.1% over the last 12 months. These declines sit against a backdrop of ongoing attention on CoStar Group's role in real...

In recent days, Kratos Defense & Security Solutions reported first-quarter 2026 results that exceeded estimates, raised its full-year 2026 revenue outlook to US$1.70–US$1.76 billion, and highlighted a sharply larger backlog supported by new defense contracts across missiles, drones, and advanced communications. Jefferies’ upgrade to a Buy rating, citing a US$14.00 billion opportunity pipeline and momentum in programs like Prometheus, hypersonics, and Valkyrie, underscores how far-reaching...

Arcutis Biotherapeutics (ARQT) is back in focus after supporting a new American Journal of Clinical Dermatology manuscript that provides practical guidance on diagnosing and managing genital psoriasis across age groups, highlighting the company’s role in clinician education. See our latest analysis for Arcutis Biotherapeutics. Despite attention on the new genital psoriasis guidance and recent restricted stock unit grants, Arcutis Biotherapeutics’ share price, at US$21.23, has fallen sharply...

Why Savers Value Village’s latest debt move matters for shareholders Savers Value Village (SVV) amended its credit agreement, cutting applicable rates on existing term loans to 2.50% for Term SOFR Loans and 1.50% for Base Rate Loans. This change directly affects interest costs. See our latest analysis for Savers Value Village. At a latest share price of US$8.99, Savers Value Village’s 1 month share price return of 11.5% contrasts with a year to date share price decline of 4.9% and a 1 year...

Why Evolution Metals & Technologies stock is on investors’ radar Evolution Metals & Technologies (EMAT) has drawn attention after a recent pullback, with the stock down about 30% over the past month and roughly 19% over the past 3 months. With a market value near US$4.0b, revenue of US$1.879m and a net loss of about US$1.0b, the company’s focus on critical materials and advanced manufacturing comes amid ongoing share price pressure. See our latest analysis for Evolution Metals &...

Qfin Holdings, Inc. recently reported first-quarter 2026 results showing revenue of CNY 3,909.33 million and net income of CNY 883.32 million, alongside second-quarter net income guidance of RMB 830–910 million. The company also announced that board member Mr. Dan Zhao resigned for personal reasons on June 3, 2026, leaving an eight-person board with six independent directors overseeing its AI-driven credit-tech operations. We’ll now examine how Qfin’s weaker first-quarter earnings and...

On May 27, 2026, RB Global, Inc. presented at Barrington Research’s 20th Annual Virtual Spring Investment Conference, drawing attention to its business performance and outlook in the commercial asset marketplace. Analysts’ optimistic views, combined with strong profitability and growth metrics and recent insider buying, are reinforcing confidence in RB Global’s underlying business strength. Against this backdrop of analyst optimism and insider confidence, we’ll now examine how the conference...

In late May 2026, JOYY Inc. reported first-quarter 2026 results, with revenue of US$555.7 million and net income of US$50.32 million, and issued second-quarter 2026 net revenue guidance of US$562 million to US$581 million, while cautioning that macroeconomic uncertainties could alter these preliminary views. An interesting wrinkle is that while net income fell sharply from a very large prior-year figure, basic earnings per share from continuing operations still increased to US$1, suggesting...

Thermo Fisher Scientific recently unveiled its Thermo Scientific Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers at the 2026 American Society for Mass Spectrometry Conference, highlighting multiomics, complex biopharma characterization and higher-throughput small-molecule analysis, alongside expanded AI-enabled proteomics capabilities from its Olink platform and recent software acquisitions. The launches underline how Thermo Fisher is deepening its role in linking early...

Why Pulse Biosciences is on investors’ radar Pulse Biosciences (PLSE) has drawn fresh attention after a period of strong share price moves, including gains over the past month and past 3 months that stand out against its recent trading history. See our latest analysis for Pulse Biosciences. Against this backdrop, the recent 32.76% 30-day share price return and 30.23% 90-day share price return sit alongside an 89.17% year-to-date share price gain and a 3-year total shareholder return of...

AdaptHealth Corp. recently appointed Daniel McFadden as Chief Operating Officer, effective May 4, 2026, and retroactively increased his annual base salary from US$410,000 to US$550,000 following board approval on May 27, 2026. This leadership change comes as investors focus on AdaptHealth’s new more than US$1 billion, five‑year capitated contract, which management expects to add about US$200 million in annual recurring revenue once fully ramped. With this large capitated contract as a...

In Q1 2026, RPC, Inc. reported a strong earnings beat, with revenue rising very large year on year and surpassing analyst expectations by a wide margin, led by its Technical Services segment despite weather-related disruptions. The company also delivered the fastest revenue growth and largest analyst estimate beat among oilfield services peers, underscoring the impact of its pressure pumping and downhole tools offerings on overall performance. Now we’ll examine how this outperformance in...

Why Uniti Group’s new fiber-backed debt deal matters for shareholders Uniti Group (UNIT) has priced about $1.14b of secured fiber network revenue term notes through subsidiary Kinetic ABS Issuer LLC, backed by residential fiber assets and customer agreements across multiple U.S. states. The company plans to use the proceeds for general corporate purposes, including capital expenditures and repayment of outstanding debt. This directly affects its capital structure, interest costs, and...

Concentrix (CNXC) is back in focus as investors weigh how effectively the company can capture expected cost and margin benefits from its Webhelp integration, while also assessing currency exposure and debt in light of recent share price moves. See our latest analysis for Concentrix. The recent 14.63% 1 month share price return contrasts with a 32.49% decline year to date and a 49.06% fall in 1 year total shareholder return, suggesting short term momentum is building while longer term...

Perrigo recently reported past first-quarter 2026 results with adjusted earnings per share above estimates but revenue below expectations, citing softer consumer demand and inventory destocking, while it reaffirmed its full-year 2026 guidance. An interesting aspect is that management kept its outlook intact despite weaker sales trends and broadly lower analyst estimates, underscoring confidence in its current plan. We’ll now assess how Perrigo’s decision to reaffirm full-year guidance...

ConnectOne Bancorp earnings and dividend momentum draw investor focus ConnectOne Bancorp (CNOB) recently topped quarterly earnings expectations, sending the stock to a new 52 week high as institutional investors added to positions and dividend metrics attracted fresh attention from income focused investors. See our latest analysis for ConnectOne Bancorp. ConnectOne Bancorp’s recent breakout to a new 52 week high comes after its strong quarterly earnings and increased institutional interest,...

In early June 2026, USA Compression Partners, LP presented at Bank of America’s Energy & Power Credit Conference and RBC Capital Markets’ Global Energy, Power & Infrastructure Conference in New York, following first-quarter 2026 results that exceeded revenue expectations and reaffirmed full-year guidance. A key insight from these updates is how the J-W Power acquisition and tight compression market are supporting USA Compression’s utilization and contract visibility. Next, we’ll examine...